Transcriptional control of antigenic variation in the malaria parasite Plasmodium falciparum. Malaria is a major health concern for the Australian Defence Personnel recently deployed in East Timor, Afghanistan and the Solomon Islands and is endemic in our immediate neighbours Indonesia and Papua New Guinea. Australia is susceptible to malaria and climate change could extend the mosquitos range to large population centres of Northern Australia causing malaria in Australia. This study would clarif ....Transcriptional control of antigenic variation in the malaria parasite Plasmodium falciparum. Malaria is a major health concern for the Australian Defence Personnel recently deployed in East Timor, Afghanistan and the Solomon Islands and is endemic in our immediate neighbours Indonesia and Papua New Guinea. Australia is susceptible to malaria and climate change could extend the mosquitos range to large population centres of Northern Australia causing malaria in Australia. This study would clarify how malaria parasites evade the host's immune response and help to protect Australia by providing drug targets for the control of this invasive disease.Read moreRead less
Discovery Indigenous Researchers Development - Grant ID: DI0668388
Funder
Australian Research Council
Funding Amount
$87,458.00
Summary
The genetic basis for bioactivity in the traditional medicine plants of Australia. A plant species that produces a bioactive compound usually produce the compound in very small amounts. To allow for marketable levels of production of the bioactive compound, numerous amounts of plants would need to be removed from the environment. This not only removes the limited supply of possibly rare types of plants from the environment but also denies the use of this plant by traditional people. Locating and ....The genetic basis for bioactivity in the traditional medicine plants of Australia. A plant species that produces a bioactive compound usually produce the compound in very small amounts. To allow for marketable levels of production of the bioactive compound, numerous amounts of plants would need to be removed from the environment. This not only removes the limited supply of possibly rare types of plants from the environment but also denies the use of this plant by traditional people. Locating and using the genes responsible for producing these bioactive compounds will allow their sustainable biosynthesis.Read moreRead less
Mechanisms of action and expression of bioactive compounds produced by the surface associated marine bacterium Pseudoalteromonas tunicata. The marine surface-associated bacterium Pseudoalteromonas tunicata produces a number of bioactive metabolites that inhibit the colonisation and growth of common fouling organisms such as bacteria, fungi, algae and invertebrate larvae. The antibacterial and antifungal compounds represent novel metabolites active against a remarkable range of both medically and ....Mechanisms of action and expression of bioactive compounds produced by the surface associated marine bacterium Pseudoalteromonas tunicata. The marine surface-associated bacterium Pseudoalteromonas tunicata produces a number of bioactive metabolites that inhibit the colonisation and growth of common fouling organisms such as bacteria, fungi, algae and invertebrate larvae. The antibacterial and antifungal compounds represent novel metabolites active against a remarkable range of both medically and agriculturally important bacteria and fungi. This project aims to explore the identity, mode of action and regulation of expression of these compounds. This research proposal addresses several significant biological concepts and will lead to the development of novel environmentally friendly antifouling and antimicrobial technologies.Read moreRead less
Evaluation of the potential of colostrum-derived anti-influenza antibody for the treatment and prevention of influenza. The project addresses a common disease problem, influenza, with a novel application of antibody technology. The technology may safely provide protection and cost effective treatment for those members of the community who are least protected by current approaches. The product can be cost-effective and readily available to enable the public to self medicate in high risk situation ....Evaluation of the potential of colostrum-derived anti-influenza antibody for the treatment and prevention of influenza. The project addresses a common disease problem, influenza, with a novel application of antibody technology. The technology may safely provide protection and cost effective treatment for those members of the community who are least protected by current approaches. The product can be cost-effective and readily available to enable the public to self medicate in high risk situations, or to be used as a public health tool in situtions to control outbreaks in those most susceptible to serious disease. The production system that enabled the creation of the technology is the advanced Australian dairy industry. Farmers with herds participating will receive a significant income benefit from, what was before, largely a waste product.Read moreRead less
Targeted isolation of specific marine bacterial species associated with higher organsims for the purpose of discovering new antimicrobial compounds. Specific bacterial species that are commonly found in association with marine plants and animals often produce active secondary metabolites. The aim of this project is to apply our understanding of these bacterial-host associations to the targeted isolation of novel antimicrobials from the marine environment. While these new compounds will undoubted ....Targeted isolation of specific marine bacterial species associated with higher organsims for the purpose of discovering new antimicrobial compounds. Specific bacterial species that are commonly found in association with marine plants and animals often produce active secondary metabolites. The aim of this project is to apply our understanding of these bacterial-host associations to the targeted isolation of novel antimicrobials from the marine environment. While these new compounds will undoubtedly have a number of commercial applications this project focuses on the development of products for dental hygiene in animals. Generally, the urgent need for new antimicrobial compounds to combat the growing number of microbes that are resistant to current antibiotics highlights the importance of this project.Read moreRead less
ARC Centre of Excellence - Structural and Functional Microbial Genomics. The research falls under the National Research Priority Frontier Technologies for Building and Transforming Australian Industries, with the priority goal of frontier technologies. The research has commercial applications, such as the development of novel antimicrobials and vaccines, with potentially enormous impact in the biotechnology area of biomedical health and the primary industries. In addition, the project will use ....ARC Centre of Excellence - Structural and Functional Microbial Genomics. The research falls under the National Research Priority Frontier Technologies for Building and Transforming Australian Industries, with the priority goal of frontier technologies. The research has commercial applications, such as the development of novel antimicrobials and vaccines, with potentially enormous impact in the biotechnology area of biomedical health and the primary industries. In addition, the project will use state-of-the-art technology, including use of synchrotron radiation at the Monash-based Australian Synchrotron facility from 2007.Read moreRead less
Exploring and harnessing mobile DNA: Integrons and gene cassettes in natural populations of Bacteria. Bacteria respond rapidly to environmental change by acquiring new genes via lateral gene transfer. The integron/gene cassette system is important in this process as it is found in an increasingly broad range of bacteria. As well as being common, we have shown that the system is associated with an unprecedented amount of genetic novelty. Here we explore the limits of this novelty and its con ....Exploring and harnessing mobile DNA: Integrons and gene cassettes in natural populations of Bacteria. Bacteria respond rapidly to environmental change by acquiring new genes via lateral gene transfer. The integron/gene cassette system is important in this process as it is found in an increasingly broad range of bacteria. As well as being common, we have shown that the system is associated with an unprecedented amount of genetic novelty. Here we explore the limits of this novelty and its contribution to bacterial evolution. In so doing we have the potential to identify new commercially important genes and develop enabling technologies. These discoveries could produce beneficial outcomes for exploitation by a wide range of Australian industries.Read moreRead less
Environmental genomics and novel bioactives from microbial communities on living marine surfaces. This project has three linked benefits to Australia. One, it is the first study to use environmental genomics analysis in an Australian marine ecosystem, thus bringing into the Australian scientific community the cutting edge technology for studying diverse microbial communities. Two, by using this technology we will be able to investigate Australian marine biodiversity to an unprecedented extent. ....Environmental genomics and novel bioactives from microbial communities on living marine surfaces. This project has three linked benefits to Australia. One, it is the first study to use environmental genomics analysis in an Australian marine ecosystem, thus bringing into the Australian scientific community the cutting edge technology for studying diverse microbial communities. Two, by using this technology we will be able to investigate Australian marine biodiversity to an unprecedented extent. Three, this newly revealed diversity will then be mined for novel bioactives for use in pharmaceutical and other human health applications. Read moreRead less
Microbial Pathogens as Selective Agents in the Evolution of Arthropod Sociality. We will reveal ecological and evolutionary forces that have shaped a major response of social insects to microbial disease, then apply the results to drug discovery. We will generate the first data on a new approach to antibiotic bioprospecting in the social insects yielding two major outcomes: First, we identify novel sources of antimicrobial compounds. Second, we demonstrate that the new, biorational approach is a ....Microbial Pathogens as Selective Agents in the Evolution of Arthropod Sociality. We will reveal ecological and evolutionary forces that have shaped a major response of social insects to microbial disease, then apply the results to drug discovery. We will generate the first data on a new approach to antibiotic bioprospecting in the social insects yielding two major outcomes: First, we identify novel sources of antimicrobial compounds. Second, we demonstrate that the new, biorational approach is a potent tool for natural product pharmaceutical bioprospecting. Both outcomes contribute directly to the National Research Priority Goal for the Sustainable Use of Australia's Biodiversity by developing new ways to find and identify novel natural resources.
Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0989564
Funder
Australian Research Council
Funding Amount
$150,000.00
Summary
State-of-the-art facility for human and animal virus research in the Canberra and surrounding regions. New viral diseases continue to emerge and old viruses re-emerge to pose a threat to human and animal health. To combat these, we propose a dedicated viral disease research facility. The centre will include experienced researchers, biotechnology companies and government agencies working on discovery, prevention and treatment of viral diseases. Forging strong scientific links between these organi ....State-of-the-art facility for human and animal virus research in the Canberra and surrounding regions. New viral diseases continue to emerge and old viruses re-emerge to pose a threat to human and animal health. To combat these, we propose a dedicated viral disease research facility. The centre will include experienced researchers, biotechnology companies and government agencies working on discovery, prevention and treatment of viral diseases. Forging strong scientific links between these organisations will considerably enhance the productivity of these researchers, increase their collaborative and scientific outputs and allow for training of students in the latest technologies. The facility will provide researchers with cutting-edge instrumentation for nationally and internationally important projects that would benefit human health.Read moreRead less